Literature DB >> 15118342

Transferrin microheterogeneity in fetal blood.

Y Wu1, H Sakamoto, K Kanenishi, S Tanaka, M Ueno, T Hata.   

Abstract

OBJECTIVES: To investigate the distribution of microheterogeneous subfractions of transferrin in fetal blood and the influence of highly sialylated transferrins on fetal growth. STUDY
METHOD: Serum transferrin concentrations were determined by a standard turbidimetric assay. Microheterogeneous transferrin subfractions were assessed by crossed immunoisoelectric focusing.
RESULTS: In normal term infants, total serum transferrin concentrations and percent distribution of highly sialylated transferrins (> or = 5-sialo-transferrins) were markedly lower; the percent distributions of hyposialylated transferrins (0- and 1-sialo-transferrins) were apparently higher than those in non-pregnant and pregnant women. There was no significant positive correlation between the serum concentrations of total transferrin or highly sialylated transferrins in infants' blood and birth weights (r = 0.187, p = 0.582; r = 0.374, p = 0.257, respectively).
CONCLUSION: The transferrin microheterogeneity pattern shifted towards reduced glycosylation and sialylation in addition to a decrease in total transferrin concentration in fetal blood compared to that of non-pregnant and pregnant women. The concentrations of serum total transferrin and the highly sialylated transferrins in fetal blood, if higher than a certain level, did not seem to have any influence on normal fetal growth. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15118342     DOI: 10.1159/000078311

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  2 in total

1.  Transferrin changes in haemodialysed patients.

Authors:  Dorota Formanowicz; Piotr Formanowicz
Journal:  Int Urol Nephrol       Date:  2011-04-01       Impact factor: 2.370

2.  The Influence of Tobacco Smoke on Protein and Metal Levels in the Serum of Women during Pregnancy.

Authors:  Marta Wrześniak; Marta Kepinska; Małgorzata Królik; Halina Milnerowicz
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.